Clinical Trials Logo

Filter by:
NCT ID: NCT04750798 Recruiting - Cardiac Arrhythmias Clinical Trials

An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias

Start date: February 22, 2021
Phase:
Study type: Observational

The purpose of this study is to prospectively collect clinical data evaluating the ongoing safety and performance during routine-use standard cardiac arrhythmia mapping and/or ablation procedures while using commercial Biosense Webster Inc. (BWI) medical devices. Data generated from the study will be used to confirm safety and performance of BWI medical devices in the marketed phase and to expand the body of evidence on the use of these devices and techniques in treatment of cardiac arrhythmias.

NCT ID: NCT04750603 Completed - Asthma in Children Clinical Trials

Effect of Fluticasone Furoate/Vilanterol on EIA in Adolescents

EIA
Start date: December 1, 2018
Phase: Phase 4
Study type: Interventional

Exercise induced asthma (EIA) is common in adolescents. (Fluticasone furoate (FF)/Vilanterol (VI)) is a once daily inhaler with bronchodilator effect lasting 24 hours. Our objective was to investigate the short and long-term effects of FF/VI on EIA in adolescents. Adolescent asthmatics were referred for evaluation of EIA. Patients with a positive exercise challenge test, were allocated to a single administration of salbutamol and 22 to FF/VI in a double blind, double dummy method to assess the short-term effect on EIA. Then they received FF/VI for 30-60 days and were reassessed by a repeat exercise test 24-hours after the last dose.

NCT ID: NCT04749940 Withdrawn - Clinical trials for Treatment of Skin Graft Donor Site

PRF Based Dressing Versus AQUACEL® for Local Treatment of Skin Graft Donor Site

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

PRF Based Dressing Versus AQUACEL® for Local Treatment of Skin Graft Donor Site: A Non-Inferiority Trial

NCT ID: NCT04749264 Completed - Mental Health Issue Clinical Trials

The Influence of Mindfulness Meditation Retreat on Attention to Internal Experience

Start date: August 1, 2020
Phase:
Study type: Observational

Although attention is thought to have a definitive functional role in mindfulness meditation training and its salutary mechanisms of action, extant empirical evidence is mixed and limited. In the proposed study, we propose to test whether 6 to 7-days mindfulness meditation retreats (N=90), relative to a wait-list control condition (N=45), will impact internal attentional processes or attention to internal experience (e.g., thoughts and bodily sensations); and whether these internal attentional change processes predict salutary outcomes of mindfulness meditation retreats. Participants will complete tasks designed to measure attention to internal experience before and then immediately following the retreat, as well as self-report measures of salutary outcomes before and 2-weeks post-retreat. Matched controls will complete the tasks at parallel time-points in the lab.

NCT ID: NCT04748172 Completed - Fertility Issues Clinical Trials

COVID-19 Vaccine and Ovarian Reserve

Start date: February 1, 2021
Phase:
Study type: Observational

As Israel is the first country to widely vaccinate its population using the mRNA vaccine against COVID-19, evaluating its influence on ovarian reserve is essential .

NCT ID: NCT04747574 Recruiting - SARS-CoV-2 Clinical Trials

Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection

Start date: September 25, 2020
Phase: Phase 1
Study type: Interventional

This is an open-label Phase I study, four dose escalation groups, to evaluate the safety of CD24-exosomes in patients with moderate/severe COVID-19 disease. Patients with moderate/severe COVID-19 infection and factors predictive of a cytokine storm are recruited from the Corona department of the Tel Aviv Sourasky Medical Center (TASMC), who have provided informed consent are being recruited in four dose groups who will receive the exosome treatment as an add-on treatment to standard treatment.

NCT ID: NCT04747418 Recruiting - Clinical trials for Cesarean Section Complications

Uterine Inflammatory Characteristics

Start date: February 1, 2021
Phase:
Study type: Observational

Data regarding fertility following niche repair is limited. It has been reported that a niche can reduce the chances of embryo implantation and may lead to spontaneous miscarriages if the implantation is close to or in the niche. One possible theory refers to inflammatory process at the area of the niche that harms the endometrial environment. Due to the aforementioned, the aim of our study is to compare the inflammatory characteristics of women with cesarean uterine scar to those without.

NCT ID: NCT04747262 Recruiting - ASD, Anxiety Clinical Trials

Administering a Parent-based Pilot Intervention for Reducing Anxiety in Children With ASD and Anxiety

Start date: January 17, 2021
Phase: N/A
Study type: Interventional

We are implementing the SPACE program, an evidence-based protocol that has been proven to be efficent in childhood anxiety disorders and OCD (Lebowitz, 2013; Lebowitz, Omer, Hermes & Scahill, 2014), in a new population of children with ASD and anxiety. The intervention aims to reduce family accommodation of the child's anxiety symptoms. The program contains 12 weekly 1-hour sessions with the parents. We will examine the impact of the intervention on family accommodation, ASD and anxiety symptomology, as well as parent and child satisfaction from the intervention, using the attached measures.

NCT ID: NCT04746092 Active, not recruiting - Multiple Myeloma Clinical Trials

The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19

Start date: January 6, 2021
Phase:
Study type: Observational

The corona pandemic is a continuing global challenge due to Corona Virus 2019 (COVID-19). The purpose of the study is to evaluate the capability of Haemato-oncology patients to generate antibodies against COVID-19 after infection and vaccination.

NCT ID: NCT04745806 Recruiting - Wounds Clinical Trials

Post Marketing Trial for Evaluating the Effectiveness of ActiGraft in Treating Lower Extremity Hard To Heal Wounds

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

The study is a prospective, single arm, post- marketing study. The subjects enrolled to the study will receive weekly applications of ActiGraft until complete healing or until investigator's decision that patient can no longer benefit from the study treatment.